Anti-Inflammatory Therapeutics Market By Drug Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Biologics, Immune Selective Anti-Inflammatory Derivatives (ImSAIDs)), By Indication (Rheumatoid Arthritis, Chronic Obstructive Pulmonary Disease (COPD), Multiple Sclerosis, Inflammatory Bowel Disease (IBD), Psoriatic Arthritis, Gout) - Growth, Future Prospects & Competitive Analysis, 2018 - 2026

$ 4325

Anti-inflammatory therapeutics market expected to reach by US$ 130.6 Bn by 2026 with CAGR of 8.5% during the forecast period from 2018 to 2026. Biologics and immune selective anti-inflammatory derivatives (ImSAIDs) are the promising drugs classes playing major role in the market.

Anti-Infective Drugs Market By Type (Anti-Bacterials, Anti-Virals, Anti-Fungals, Others), By Range (Broad Spectrum, Narrow Spectrum) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

$ 4325

The growing prevalence of infections such as influenzas, ebola virus and HIV have brought significant changes in the outlook of the general population about infections and their management, and consequently in the consumption of anti-infective agents.

Anti-aging Services Market By Type (Microdermabrasion, Liposuction, Breast Augmentation, Chemical Peel, Sclerotherapy, Botox, Dermal Fillers and Others), By Demographics (Baby Boomers, Generation X and Generation Y) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The anti-aging services market is set to reach from US$ 22,518.8 Mn in 2017 to US$ 35,597.9 Mn by 2026 at a compound annual growth rate (CAGR) of 5.3% during the forecast period from 2018 to 2026. Aging is a biological process of becoming older which is characterized by changes in physical appearances such as greying of hair, wrinkles on face, saggy skin and decreased skin tone and texture. Oxidative stress and unhealthy eating habits stimulates the formation of free radical species which promotes cellular aging. Rising external appearance consciousness and availability of diverse range anti-aging products drive the anti-aging services market growth.

Anemia Treatment Drugs Market By Type Of Anemia (Iron Deficiency Anemia, Thalassemia, Aplastic Anemia, Hemolytic Anemia, Sickle Cell Anemia, Pernicious Anemia), By Type Of Drug (Supplements, Antibiotics, Immunosuppresants, Bone Marrow Stimulants, Corticosteroids, Gene Therapy, Iron Chelating Agents) - Growth, Future Prospects And Competitive Landscape, 2018 – 2026

$ 4325

Anemia treatment drugs market accounted for a market value of US$ 23,155.8 Mn in 2017 and projected to grow at a CAGR of 16.4% during the forecast period from 2018 to 2026. An abnormal decrease in the level of red blood cells, irregular red blood cell morphology, or inadequate concentration of haemoglobin in the blood results in anemia. Anemia is caused also due to numerous nutritional and non-nutritional factors such as infectious disease including malaria, soil-transmitted- helminthiasis, hookworm, and tuberculosis).

Allergy Immunotherapy Market By Type Of Allergy (Food Allergy, Allergic Rhinitis, Skin Allergy, Insect-Bite Allergy, Other Allergies), By Type Of Treatment (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT) ) - Growth, Future Prospects, And Competitive Landscape, 2018 - 2026

$ 4325

Allergy immunotherapy market accounted for a market value of US$ 1,499.0 Mn in 2017 and projected to grow at a CAGR of 10.1% during the forecast period from 2018 to 2026. Allergy immunotherapy helps to prevent or minimize the allergic reactions and provide log-term benefit to patients. This therapy helps to increase immunological tolerance and changes the course of disease due to which demand for immunotherapy is increasing globally.

Active Pharmaceutical Ingredient Market By API Type (Synthetic Chemical API, Biological API), By Drug Type (Branded Drugs, Generic Drugs, Otc Drugs), By Manufacturing Type (Contract Manufacturers, Captive Manufacturers) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The global active pharmaceutical ingredient market is growing significantly, valuing at US$ 152.6 Bn in 2017 and expected to reach US$ 273.7 Bn by 2026. Worldwide growing chronic diseases along with rising incidences for respiratory, cardiovascular, and oncology drives the overall market growth during the forecast period. In addition, new technological progresses in biologics & other specialty drugs along with favorable public and private funding in the pharmaceutical sector across various developing countries will further assist in the API market growth.

Specimen Validity Test (SVT) Reagents Market By Location Type (On-Site Screening, Laboratory-based Screening) - Growth, Future Prospects, and Competitive Analysis, 2017 - 2025

$ 4325

Specimen validity test (SVT) primarily involve evaluation urine sample for detection of adulterant or dilution in drug testing specimen. Increase in number of drug abuse population and stringent regulatory guidelines enforced by regulatory agencies in developed countries such as United States are prime factors that are driving the growth of SVT reagent market. North America alone contributing more than 65 percent of total market share.

Pharmaceutical Intermediates Market By Product (Bulk Drug Intermediates, Chemical Intermediates, Custom Intermediates), By End User (Pharmaceutical & Biotechnology Companies, Contract Manufacturing Organization, Research Laboratories) - Growth, Future Prospects & Competitive Analysis, 2019 – 2027

$ 4325

The pharmaceutical intermediates market is set to reach from US$ 25,965.0 Mn in 2018 to US$ 36,890.6 Mn by 2027 at a compound annual growth rate (CAGR) of 4.0% during the forecast period from 2019 to 2027. Significant rise in drug formulation and research activities and supportive regulatory environment provided by global healthcare agencies will consolidate the pharmaceutical intermediates market during the forecast period.

Post-Traumatic Stress Disorder Therapeutics Market By Drug Class (Antidepressants, Anti-Anxiety Drugs, Other Drug Classes, Pipeline Candidate) - Growth, Future Prospects & Competitive Analysis, 2018 - 2026

$ 4325

The global post-traumatic stress disorder therapeutics market expected to reach 10,679.5 Mn by 2026 with CAGR of 4.5% during the forecast period from 2018 to 2026. Antidepressants including SSRIs (Zoloft and Paxil) are among the first line of treatment for PTSD, dominated the global market in 2017 and projected to retain its dominance during the forecast period. North America dominated the PTSD therapeutics market with more than 50% of market share for the year 2017. 

Glycogen Market By Source (Plant Based, Animal Based), By Application (Personal Care & Cosmetics, Food, Sports Nutrition, Pharmaceuticals, Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The global glycogen market volume was at 2,176.6 Ton in 2017, and expected to grow at 5.8% CAGR during the forecast period from 2018 to 2026. Glycogen is a multi-branched glucose polysaccharide that acts as an energy reservoir in animals, humans, bacteria and fungi.

Painful Diabetic Neuropathy Drugs Market By Drug Type (Nucynta/Palexia, Lyrica, Cymbalta, Qutenza (8% Capsaicin patch), Tricyclic Antidepressants, Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Anticonvulsants, Opioids, Pipeline Analysis) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

Global painful diabetic neuropathy (PDN) drugs market accounted to US$ 4,811.8 Mn in 2017 and expected to attain US$ 8,962.0 by 2026 growing at a CAGR of 6.6% during the forecast period from 2018 to 2026. Of the various marketed drugs analyzed, Lyrica accounted for maximum market share in 2017 while Qutenza will exhibit fastest CAGR during the forecast period from 2018 to 2026. Lyrica and Cymbalta are the only recommended first line of therapy for PDN thus depicting dominance throughout the study period from 2016 to 2026.

Pharmacovigilance Market By Drug Development (Preclinical Studies, Phase I, Phase II, Phase III, Phase IV Or Post Marketing Surveillance), By Reporting Methods (Spontaneous Reporting, Intensified Adr Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Ehr Mining), By Services (In-house, Contract Outsourcing) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

$ 4325

Exaggerating regulatory compliance, efficient maintenance of product life cycle and the growing need of prompt patient reporting has boost the need for pharmacovigilance. Pharmaceutical companies are increasingly entering into long term arrangements with CROs and BPOs for performing pharmacovigilance activities initiating from drug discovery phase to post market surveillance.

Allergy Diagnostics And Treatment Market By Product Type (Assay Kits, Consumables, Services), By Test Type (In Vivo Tests, In Vitro Tests), By Treatment Type (Antihistamines, Autoinjectable Epinephrine, Corticosteroids, Decongestants, Immuno Modulators, Immunotherapy, Leukotriene Inhibitors, Mast Cell Stabilizers, Nasal Anticholinergics), By Allergen Type (Food Allergen, Inhaled Allergen, Drug Allergen, Other Allergen) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

$ 4325

Allergy is the immune reaction to foreign body called allergen; it may arise due to food consumed or inhaled into lungs or in contact with skin through injectable agent or touch. Allergic diseases rank fifth among the leading chronic diseases across all age groups in U.S. Over the period of 50 years of global industrialization, there is a substantial rise in prevalence of allergic diseases.

Mycosis Fungoides Market By Treatment (Topical Steroids, Mechlorethamine Gel, HDAC Inhibitors, Monoclonal Antibodies, Localized Radiation Therapy, Extracorporeal Photopheresis, Others) Growth, Future Prospects And Competitive Analysis, 2019 - 2027

$ 4325

The mycosis fungoides market is set to project sublime growth at a compounded annual growth rate (CAGR) of 4.9% during the forecast period from 2019 to 2027. Mycosis fungoides occurs in 70% of the patients suffering with cutaneous T cell lymphoma (CTCL), affecting initially to the skin later the infection spreads to internal organs in the later stages of the disease. Currently combinatorial treatment regimen is employed by oncologist worldwide to subdue the clinical manifestation occurring during the course of disease.

Macrogol Laxatives Market By Drug Name (Movicol; Casenlax; VistaPrep; CosmoCol; Molaxole; Endofalk; Glycoprep; Forlax; Laxido; MiraLAX and Other Macrogols), By Disease (Inflammatory Bowel Diseases (IBD); Irritable Bowel Syndrome (IBS); Drug Induced Constipation (DIC); and Other Diseases), By Age Group (Baby Boomers and Older; Generation X; Millennials; Generation Z; and Generation Alpha) - Growth, Future Prospects and Competitive Analysis, 2020 – 2027

$ 4325

Constipation is a very common condition across the world both in adults and children and it impacts the physical and emotional well-being considerably. In adults, the frequency of constipation differs from 2.5% to 79% whereas; in children it is about 0.7% to 29.6%. It has been found that constipation becomes more frequent after the age of 60 years.

Central Fill Pharmacy Automation Market By Product & Service Type (Equipment, Software, Services), By Vendor (Equipment Vendors, Sales & Consulting Vendors) - Growth, Future Prospects And Competitive Analysis, 2019 – 2027

$ 3800

The global central fill pharmacy automation market is developing competently, expected to grow at a CAGR of 10.1%. Globally, increasing penetration of pharmacy automation products, advancement in robotics & tabletop devices, and growth in overall software & services for enhanced distribution of pharmaceutical drugs will drive the overall market growth. Rising awareness about central fill automation technology along with the launch of integrated software solutions are key factors driving the growth of the central fill pharmacy automation market on a global scale.

Algae Products Market By Type (Spirulina, Chlorella, Astaxanthin, Beta Carotene, Hydrocolloids), By Source (Brown, Blue – Green, Green, Red, Others), By Application (Nutraceuticals, Food & Feed Supplements, Pharmaceuticals, Paints & Colorants, Chemicals, Fuels, Others) - Growth, Share, Opportunities & Competitive Analysis, 2019 – 2027

$ 3800

The rising application of algae in nutraceuticals & pharmaceutical industries has influenced the market growth in the recent past. The growing use of algae biomass for nutraceuticals purposes is expected to provide an attractive revenue stream for algae producers. Further, the growing industrial application of algae is providing business opportunities to the companies that have further impacted the market growth.

Inhalation Anaesthesia Market By Product (Desflurane, Sevoflurane, Isoflurane), By Outlook (Induction Anaesthesia, Maintenance Anaesthesia) - Industry Size, Growth, Share And Forecast To 2026

$ 3800

Inhalation anaesthesia refers to chemical compounds that have general anaesthetic properties and are administered to a patient via inhalation. The global Inhalation anaesthesia market is expected to rise with a CAGR of over 3.5% over forecast period of 2019-2026. Anaesthesia as defined by the Food and Drug Administration (FDA, US) refers to reversible state of unconsciousness resulting in lack of pain and muscle relaxation important for performing surgical procedures.

Throat Lozenges Market By Ingredients (Mint, Eucalyptus Oil, Peppermint Oil, Menthol, Honey and Ginger, Lemon, Others), By Type (Hard Candy Lozenges, Soft Lozenges, Compressed Lozenges) - Industry Size, Growth, Share And Forecast To 2026

$ 3800

Throat lozenges are medicated tablets that are used for temporary treatment of sour throat, cough and others. The tablets are intended to slowly dissolve in mouth to soothe and lubricate irritated tissues of the throat and to stop coughs. The throat lozenges are available for sale through over the counter sales and generally may be dispensed without a prescription. The global market for throat lozenges is expected to witness a substantial growth growing with a CAGR of over 4% over the forecast period of 2019-2026. Cold and cough are among the most common diseases, an adult approximately 2 to 4 times is effected by cold in a year as per National Prescribing Service (NPS, Australia). High incidences of cold and cough, growing geriatric population along with growing air population act as key drivers for the growth of the market.

Pharmaceutical

The global pharmaceuticals market has been consistent of large companies based in US and Europe.  The pharma market is a challenging one and is constantly evolving to meeting the healthcare needs of a growing population. While generic drugs have dominated the market in developing countries the demand for the latest drug discoveries and better healthcare is increasing demand in these countries. The pharmaceutical industry has seen high level of mergers and acquisition which are helping it grow in a rationalized fashion.

Our reports help identify key industry statistics and trends. Brisk Insights focuses on important performance geographies and competitive analysis.